Androvia LifeSciences focuses on diagnosing & treating male fertility. Androvia’s Cap-Score™ is the only test of sperm fertilizing ability that prospectively predicts a man’s probability of generating pregnancy (AMA CPT [PLA 0255U] approved, CLIA compliant, CAP accredited, NJ CLIS & NY CLEP licensed). Cap-Score collection kits are used through clinics or mailed to patients.